Zeleciment Basivarsen

basivarsen · Dyne Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zeleciment Basivarsen, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 [Phase 3]

See pricing